SCHEMBL23745655

SCHEMBL23745655

Cc1cccc(C(CC(=O)NC2CCNCC2)c2cn(CCC3CCCCC3)c3ccccc23)c1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.42
MAPT P10636 1/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KMT2A Q03164 4/20 0.40
CYP3A4 P08684 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
RAB9A P51151 1/20 0.39
IDO1 P14902 2/20 0.39
HTR4 Q13639 1/20 0.38
LMNA P02545 1/20 0.37
MEN1 O00255 2/20 0.37
EDNRA P25101 1/20 0.37
CNR1 P21554 1/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23721917 0.99 CNR2 (0.41) CNR2MAPTTP53TSHRL3MBTL1
SCHEMBL23745802 0.93 CNR1 (0.42) CNR2MAPTTP53TSHRL3MBTL1
Hydrochloric Acid SCHEMBL23722145 0.92 CNR1 (0.41) CNR2MAPTTP53TSHRL3MBTL1
SCHEMBL23745461 0.92 CNR1 (0.41) MAPTTP53TSHRL3MBTL1KMT2A
Hydrochloric Acid SCHEMBL23722020 0.91 CNR1 (0.40) MAPTTP53TSHRL3MBTL1KMT2A
SCHEMBL23745555 0.91 CNR2 (0.43) CNR2MAPTTP53TSHRL3MBTL1
SCHEMBL23745794 0.90 MAPT (0.40) CNR2MAPTTP53KMT2AMEN1
Hydrochloric Acid SCHEMBL23721864 0.89 MAPT (0.40) CNR2MAPTTP53KMT2AHTR4
SCHEMBL23745572 0.89 ICMT (0.41) MAPTKMT2ACYP3A4HPGDCYP2C19
SCHEMBL23745789 0.88 MAPT (0.40) MAPTTP53TSHRL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF BIOIMICS AB (SE) 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF FDPS, FPR1, F12 CNR2 2528/4885MAPT 4743/4885TP53 3651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.